Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients

scientific article published on 10 April 2017

Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.14744/ANATOLJCARDIOL.2017.7664
P932PMC publication ID5731256
P698PubMed publication ID28430117

P2093author name stringJia Hao
Jun Zhao
Qian Sun
Qiang Tan
Shuangyue Zhang
Xiaoyi Zou
P2860cites workEffects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years' follow-upQ48770909
Circulating Endothelial Progenitor Cells were Increased in Patients with Thin-Cap Fibroatheroma.Q52794628
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.Q53357001
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designQ55263071
Inflammation of left atrial epicardial adipose tissue is associated with paroxysmal atrial fibrillationQ64125478
Endothelial cell function during atrial fibrillation and after restoration of sinus rhythmQ80262874
Inflammation and C-reactive protein in atrial fibrillation: cause or effect?Q26865381
Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillationQ28607864
Histological substrate of atrial biopsies in patients with lone atrial fibrillationQ34742809
Role of inflammation in atrial fibrillation pathophysiology and management.Q35688023
Long-term Prognosis of Paroxysmal Atrial Fibrillation and Predictors for Progression to Persistnt or Chronic Atrial Fibrillation in the Korean PopulationQ35778583
Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial FibrillationQ35851738
Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysisQ39339098
Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery diseaseQ39471236
Statin therapy decreased the recurrence frequency of atrial fibrillation after electrical cardioversion: a meta-analysisQ41662211
Statins Do Not Reduce Atrial Fibrillation After Cardiac Valvular Surgery: A Single Centre Observational StudyQ42067173
Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).Q43630565
High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversionQ43834837
Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trialQ48591201
P433issue2
P921main subjectAtrial FibrillationQ815819
P304page(s)103-107
P577publication date2017-04-10
P1433published inAnatolian Journal of CardiologyQ15716765
P1476titleFluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients
P478volume18

Reverse relations

cites work (P2860)
Q93022311Outcome reporting from clinical trials of non-valvular atrial fibrillation treated with traditional Chinese medicine or Western medicine: a systematic review
Q47134000Statins in paroxysmal atrial fibrillation: Beneficial to prevent recurrence but insufficient to stop progression to prevent recurrence but insufficient to stop progression

Search more.